Nothing fully stops aging, but specific biological processes drive it, and many of them can be slowed. Genetics accounts for roughly half of lifespan variation, which means the other half comes down to environment, habits, and the cumulative choices you make over decades. Understanding what actually happens inside your cells as you age is the first step toward knowing which interventions have real evidence behind them.
What Actually Causes Aging at the Cellular Level
Aging isn’t one thing. It’s at least five overlapping processes happening simultaneously in your cells, each reinforcing the others. The most fundamental is genomic instability: your DNA accumulates damage over time from both external exposures (UV light, pollution, toxins) and internal errors during cell division. Your body has repair systems for this, but they become less efficient with age, allowing mutations to pile up.
Your chromosomes also lose their protective caps, called telomeres, with every cell division. Most human cells don’t produce the enzyme that rebuilds telomeres, so these caps get shorter throughout life. Once telomeres become critically short, cells either stop dividing or begin to malfunction. Meanwhile, epigenetic changes (shifts in how your genes are switched on and off) drift further from their original settings as you get older, altering DNA methylation patterns and protein packaging around your chromosomes.
Two other hallmarks complete the picture. Your cells gradually lose the ability to clean up damaged or misfolded proteins, a quality-control system called proteostasis. The machinery that folds proteins correctly and the recycling systems that break down cellular waste both decline. And your mitochondria, the structures that generate energy inside every cell, accumulate their own mutations at a faster rate than the rest of your DNA because they sit in an oxidative environment and have fewer repair tools. Together, these five processes create a feedback loop: damaged DNA produces faulty proteins, faulty proteins impair energy production, and reduced energy makes repair harder.
How Chronic Inflammation Accelerates the Process
Low-grade, persistent inflammation is one of the strongest accelerators of aging. Unlike the acute inflammation you feel after a cut or infection, this background inflammation simmers for years without obvious symptoms. It’s driven partly by senescent cells, which are old cells that stop dividing but refuse to die. These cells secrete inflammatory signals that damage surrounding tissue.
Interleukin-6, one key inflammatory marker, illustrates the stakes. Research from the Whitehall II study found that blood levels of IL-6 at or above 2.0 nanograms per liter cut the odds of “successful aging” (staying free of major chronic disease with intact physical and cognitive function) roughly in half compared to people with lower levels. C-reactive protein, another common marker, tends to rise with age but often stays within normal clinical ranges, which means standard blood tests can miss the slow inflammatory drift that matters most for long-term health.
Exercise and Telomere Protection
Not all exercise affects aging the same way. A controlled study comparing endurance training, high-intensity interval training, and resistance training found that both endurance and interval exercise increased telomerase activity (the enzyme that rebuilds telomere caps) by two to three-fold in immune cells. Resistance training did not produce this effect. The endurance groups also showed increases in actual telomere length across multiple cell types, while the strength-training group did not.
Even a single session of endurance exercise acutely boosted telomerase activity in specific immune cell populations. This doesn’t mean strength training is useless for aging. It preserves muscle mass, bone density, and metabolic health, all of which matter enormously as you get older. But for the specific goal of protecting telomeres, cardio and interval work appear to have a distinct biological advantage.
Sleep and Brain Waste Clearance
Your brain has its own waste-removal system, called the glymphatic system, that operates primarily during deep sleep. During slow-wave sleep, the spaces between brain cells physically expand, allowing cerebrospinal fluid to flush through and carry away metabolic waste, including beta-amyloid, the protein that accumulates in Alzheimer’s disease.
This is where aging creates a vicious cycle. Older adults naturally experience less deep sleep, more nighttime awakenings, and lower overall sleep efficiency. These changes reduce glymphatic activity, which allows waste to build up, which in turn damages brain tissue and can further disrupt sleep. Prioritizing sleep quality, not just duration, directly supports one of the brain’s primary defenses against neurodegeneration.
Fasting and Cellular Recycling
Autophagy, your cells’ recycling program, breaks down damaged components and repurposes the raw materials. It’s one of the body’s most important anti-aging mechanisms, and fasting is its strongest known trigger. In animal studies, autophagy markers increase significantly after 24 hours without food, with even more dramatic effects at 48 hours. In mouse brain cells specifically, the number of active recycling structures increased three to four-fold after food restriction.
Translating exact fasting timelines from mice to humans is imperfect, but the biological pathway is conserved across species. Several compounds found in food also appear to mimic some of fasting’s effects on autophagy. Spermidine, found in wheat germ, aged cheese, and mushrooms, has shown cardioprotective and neuroprotective effects in animals and modest cognitive benefits in human pilot studies using doses of about 1.2 to 6 milligrams per day. Resveratrol, present in grapes and wine at typical dietary intakes of 0.1 to 8 milligrams daily, activates some of the same cellular stress-response pathways, though human longevity data remains limited.
The NAD+ Decline
One molecule sits at the intersection of nearly every aging pathway: NAD+, a coenzyme your cells need for energy metabolism and DNA repair. NAD+ levels drop substantially with age, and this decline impairs a family of proteins called sirtuins that depend on it. Sirtuins regulate everything from mitochondrial function to inflammation to stress responses. In animal models, restoring NAD+ levels to youthful ranges prevented age-associated metabolic decline and extended lifespan, but these effects required functioning sirtuins to work, confirming that NAD+ operates through this specific pathway rather than acting as a general tonic.
Sun Exposure and Skin Aging
Ninety percent of visible skin aging comes from cumulative UV exposure, not from the passage of time itself. The remaining 10 percent is attributed to high-energy visible light and infrared radiation. Intrinsic aging (the kind that happens regardless of sun exposure) accounts for comparatively little of what you actually see in the mirror. This makes sun protection the single most effective cosmetic anti-aging intervention available, and one of the simplest to act on.
Measuring Your Biological Age
Chronological age is a rough proxy for how old your body actually is. Epigenetic clocks, which analyze chemical modifications on your DNA, offer a more precise measure. The original Horvath clock, one of the most validated tools, estimates biological age with an average error of about 3.6 years across diverse tissue types, though it tends to underestimate age in people over 60. A newer version called GrimAge is considered more clinically useful because it correlates strongly with mortality risk, walking speed, grip strength, frailty, and cognitive test scores.
Machine learning approaches have pushed accuracy even further. One model called DeepMAge achieves a median error of roughly 2.77 years. These tools are increasingly available through consumer testing services and give you a way to track whether lifestyle changes are moving your biological age in the right direction over time.
Drugs That Target Aging Directly
The most ambitious clinical effort to treat aging as a medical condition is the TAME trial (Targeting Aging with Metformin), which is testing whether a widely used diabetes drug can delay the onset of age-related diseases as a group. The trial enrolls 3,000 adults aged 65 to 79 without diabetes, giving them either metformin or a placebo for four years. Rather than targeting a single disease, the study tracks a composite of heart attack, heart failure, stroke, cancer, cognitive impairment, and death. It was designed with input from the FDA specifically to create a regulatory pathway for drugs that target aging itself.
Another class of compounds called senolytics aims to selectively kill senescent cells, the inflammatory “zombie cells” that accumulate with age. Early-stage human trials are underway, though no senolytic drug has yet received approval for aging-related use. The field is moving quickly, but practical, prescription-level anti-aging drugs remain years away from widespread clinical use.